Evidence map›Paper›PMID 31729633›Full record

ArticleLifetime data analysis2020

Group sequential tests for treatment effect on survival and cumulative incidence at a fixed time point.

Michael J Martens, Brent R Logan

Abstract read
In one paragraph

Article in Lifetime data analysis, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Michael J MartensThe Emmes Company, Rockville, MD, 20850, USA. mmartens@emmes.com.ORCID 0000-0003-3799-681X
Brent R LoganDivision of Biostatistics, Medical College of Wisconsin, Milwaukee, WI, 53226, USA.ORCID 0000-0002-4473-4044

Funding

Data Resource for Analyzing Blood &Marrow TransplantsU24CA076518 · NCI · MEDICAL COLLEGE OF WISCONSIN · PI Amy M Moskop, Bronwen Shaw · 1998 to 2026
$105.2M
Blood and Marrow Transplant Clinical Trials Network DCC- The Medical College of Wisconsin, Inc.U24HL138660 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Steven M. DeVine, Mehdi Hussain Hamadani · 2017 to 2026
$71.4M
Easy-to-read Informed Consent for HCT Clinical TrialsU10HL069294 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI HOROWITZ, MARY MARESCA · 2011 to 2016
$43.8M
PROLACTIN RECEPTOR COMPLEX IN BREAST CANCERR01CA069294 · NCI · UNIVERSITY OF PENNSYLVANIA · PI CLEVENGER, CHARLES V · 1996 to 2006
$1.9M
Competing Risks Analysis Methods for Group Sequential and Adaptive DesignsF31HL134317 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI MARTENS, MICHAEL JOHN · 2016 to 2016
$33k
NCI NIH HHS U10HL069294NCI NIH HHS U24 CA076518NHLBI NIH HHS F31 HL134317NHLBI NIH HHS U10 HL069294NHLBI NIH HHS U24 HL138660
6 · The paper itself

Abstract

Medical research frequently involves comparing an event time of interest between treatment groups. Rather than comparing the entire survival or cumulative incidence curves, it is sometimes preferable to evaluate these probabilities at a fixed point in time. Performing a covariate adjusted analysis can improve efficiency, even in randomized clinical trials, but no currently available group sequential test for fixed point analysis provides this adjustment. This paper introduces covariate adjusted group sequential pointwise comparisons of survival and cumulative incidence probabilities. Their test statistics have an asymptotic distribution with independent increments, permitting use of common stopping boundary specification methods. These tests are demonstrated through a redesign of BMT CTN 0402, a clinical trial that evaluated a prophylactic treatment for adverse outcomes following blood and marrow transplantation. A simulation study demonstrates that these tests maintain the type I error rate and power at nominal levels under a variety of settings involving influential covariates.

Indexed as

BiasRegression AnalysisSurvival AnalysisTreatment OutcomeClinical Trials as TopicComputer SimulationHumansIncidenceTimeCompeting risksDirect binomial regressionGraft versus host diseaseGroup sequential designHematopoietic cell transplantationSurvival analysis

Identifiers

PMID31729633
PMCPMC7365590

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.